MILLENNIUM MANAGEMENT LLC

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 1273087 NEW YORK, NY

Position in ATNM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$561,777

-$256,399 QoQ

Shares Held

564,600

-6.2% QoQ

Ownership

1.80%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. ATNM ranks #294 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	1,262,511	$238,677,704
2	INSM	INSMED Inc	1,157,786	$189,321,166
3	BMRN	Biomarin Pharmaceutical Inc	3,010,308	$170,052,298
4	TERN	Terns Pharmaceuticals, Inc.	3,011,558	$158,769,337
5	ALNY	Alnylam Pharmaceuticals, Inc.	447,887	$148,192,371
6	FOLD	AMICUS THERAPEUTICS, INC.	7,908,459	$114,356,317
7	ARDX	Ardelyx, Inc.	17,842,370	$106,875,796
8	BLTE	Belite Bio, Inc	570,088	$90,894,830

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$561,777	564,600	-6.2%	Shares	Sole	2026-05-15
2025-12-31	$818,176	601,600	-3.7%	Shares	Sole	2026-02-17
2025-09-30	$999,515	624,697	-5.8%	Shares	Sole	2025-11-14
2025-06-30	$928,576	663,269	+464.7%	Shares	Sole	2025-08-14
2024-12-31	$147,992	117,454	-26.6%	Shares	Sole	2025-02-14
2024-09-30	$301,031	160,123	+661.1%	Shares	Sole	2024-11-14
2024-06-30	$155,681	21,038	-68.8%	Shares	Sole	2024-08-14
2024-03-31	$527,828	67,411	-70.8%	Shares	Sole	2024-05-15
2023-03-31	$2,184,575	231,172	+329.8%	Shares	Sole	2023-05-15
2022-12-31	$572,757	53,780	+9.4%	Shares	Sole	2023-02-14
2022-09-30	$362,712	49,148	+48.3%	Shares	Sole	2022-11-14
2022-06-30	$159,403	33,140	-39.8%	Shares	Sole	2022-08-15
2020-12-31	$429,156	55,020	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.